AGP Picks
View all

Vaxelis market outlook points to stronger demand through 2035

12 hours ago
Vaxelis market outlook points to stronger demand through 2035
By AI, Created 14:30 UTC, Nov 19, 2026, AGP -

The Business Research Company says the Vaxelis market will keep growing as pediatric vaccination programs expand, hepatitis B cases persist, and healthcare spending rises. North America led the market in 2025, while the report flags combination vaccines and simpler immunization schedules as major demand drivers.

Why it matters: - Vaxelis is a hexavalent vaccine that protects infants and children against six diseases in one shot, which can simplify childhood immunization schedules. - The market’s growth matters because broader vaccine access, higher pediatric immunization rates and stronger supply chains can improve coverage for preventable diseases. - The report frames Vaxelis as part of a wider shift toward combination vaccines in public health programs.

What happened: - The Business Research Company released its "Vaxelis Market Report 2026 – Market Size, Trends, And Forecast 2026-2035." - The report says North America led the Vaxelis market in 2025. - The report covers Asia-Pacific, Western Europe, Eastern Europe, South America, the Middle East and Africa. - A free sample of the report is available here. - The full report is available here.

The details: - Vaxelis is designed to protect against diphtheria, tetanus, whooping cough, polio, Haemophilus influenzae type B and hepatitis B. - The vaccine is primarily used in routine childhood immunization schedules. - Historical market growth was supported by broader childhood immunization coverage, the use of combination vaccines in public health programs, improved vaccine manufacturing scalability, higher government procurement and greater awareness of preventable diseases. - Forecast growth is expected to be driven by global vaccination campaigns, preference for simplified immunization regimens, more investment in vaccine development, stronger supply chains and expanded access in emerging markets. - The report identifies growing acceptance of combination vaccines, more attention to pediatric immunization programs, demand for single-dose multivalent vaccines, broader national vaccination schedules and better cold-chain management as key trends. - The expanding pediatric population is a major demand driver because Vaxelis reduces the number of injections needed for children. - Child Stats said the United States had about 72.5 million children in 2022 and projected that figure to reach 78.2 million by 2050. - Rising hepatitis B cases also support demand for Vaxelis because the vaccine includes hepatitis B surface antigen. - The CDC reported 2,214 new acute hepatitis B cases and 1,769 hepatitis B-related deaths in 2023. - Rising healthcare spending is also supporting vaccine uptake by funding medical infrastructure, vaccination programs and public awareness campaigns. - The UK Health Foundation said planned Department of Health and Social Care spending is projected to rise from $265.4 billion (£215.6 billion) in 2025/26 to $303.9 billion (£246.8 billion) by 2028/29, a real-terms annual increase of 2.8%.

Between the lines: - The report suggests Vaxelis benefits from the same market forces pushing healthcare systems toward fewer appointments, simpler dosing and wider routine coverage. - The combination-vaccine trend could be especially important in emerging markets, where health systems often need efficient ways to expand immunization access. - The regional lead for North America indicates mature immunization infrastructure, but the broader forecast points to growth opportunities outside the region.

What's next: - The report expects the market to keep expanding as vaccination campaigns broaden and more countries add or strengthen combination-vaccine programs. - Future demand will likely depend on supply-chain resilience, cold-chain performance and government purchasing decisions. - The Business Research Company says its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, hotspot infographics and updated graphics and tables. - More information is available from the company at www.thebusinessresearchcompany.com and its social channels, including LinkedIn, Facebook and X.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

World Politics Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

World Politics Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.